RT Journal Article
SR Electronic
T1 Creating virtual H&E images using samples imaged on a commercial CODEX platform
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.02.05.21249150
DO 10.1101/2021.02.05.21249150
A1 Paul D. Simonson
A1 Xiaobing Ren
A1 Jonathan R. Fromm
YR 2021
UL http://medrxiv.org/content/early/2021/02/08/2021.02.05.21249150.abstract
AB Multiparametric fluorescence imaging via CODEX allows the simultaneous imaging of many biomarkers in a single tissue section. While the digital fluorescence data thus obtained can provide highly specific characterizations of individual cells and microenvironments, the images obtained are different from those usually interpreted by pathologists (i.e., H&E slides and DAB-stained immunohistochemistry slides). Having the fluorescence data plus co-registered H&E or similar data could facilitate adoption of multiparametric imaging into regular workflows, as well as facilitate the transfer of algorithms and machine learning previous developed around H&E slides. Since commercial CODEX instruments do not produce H&E-like images by themselves, we developed a staining protocol and associated image processing to make “virtual H&E” images that can be incorporated into the CODEX workflow. While there are many ways to achieve virtual H&E images, including use of a fluorescent nuclear stain and tissue autofluorescence to simulate eosin staining, we opted to combine fluorescent nuclear staining (via DAPI) with actual eosin staining. We also output images derived from fluorescent nuclear staining and autofluorescence images for additional evaluation.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNAFunding StatementThis work was funded by the University of Washington Department of Laboratory Medicine and Pathology and by a grant from the Brotman Baty Institute for Precision Medicine (PDS).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All methods were carried out in accordance with relevant guidelines, regulations, and approval by the institutional review board of the University of Washington (IRB #43066).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesRelevant python code and example data files will be made available at github.com/SimonsonLab/VirtualHE. https://github.com/SimonsonLab/VirtualHE